Taiwanese Pharmaceuticals & Biotech Top Dividend Payers

Syngen BiotechLtd

Market Cap: NT$2.9b

Engages in the research, development, manufacturing, and sale of microbial pharmaceutical raw materials, biological pesticides, fertilizers and biochemical nutritional products, and preventive medicines in Taiwan, China, and internationally.

TTY Biopharm

Market Cap: NT$19.7b

Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan, the United States, and internationally.

Bora Pharmaceuticals

Market Cap: NT$57.6b

Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.

Chi Sheng Pharma & Biotech

Market Cap: NT$1.7b

Manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally.

Standard Chemical & Pharmaceutical

Market Cap: NT$11.1b

Manufactures and sells pharmaceutical products in Taiwan and internationally.

TSH Biopharm

Market Cap: NT$2.0b

Develops and markets pharmaceutical products in Taiwan.

YungShin Global Holding

Market Cap: NT$13.9b

Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.

Sunmax Biotechnology

Market Cap: NT$21.3b

A biomedical company, develops, manufactures, and markets biomedical grade collagen and skin care product in Taiwan and Mainland China.

Sinphar PharmaceuticalLtd

Market Cap: NT$5.9b

Engages in the production, processing, selling, and trading of various medicines, chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

Formosa Laboratories

Market Cap: NT$6.7b

Manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

SYN-TECH Chem. & Pharm

Market Cap: NT$3.2b

Manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally.

Nang Kuang Pharmaceutical

Market Cap: NT$3.6b

Manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally.